Company: RPID
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001380106-25-000174
Chunk: 204

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 204
---
-in capital552,502 550,157 Accumulated deficit(498,395)(475,274)Accumulated other comprehensive income(2)39 Total stockholders’ equity54,545 75,352 Total liabilities and stockholders’ equity$75,586 $98,169 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Table of Contents

RAPID MICRO BIOSYSTEMS, INC.

Condensed consolidated statements of operations

(Unaudited)

(In thousands, except share and per share amounts)

Three Months Ended June 30,Six Months Ended June 30,2025202420252024Revenue:Product revenue$4,802 $4,537 $8,903 $8,250 Service revenue2,460 2,081 5,564 3,979 Total revenue7,262 6,618 14,467 12,229 Costs and operating expenses:Cost of product revenue5,315 4,917 10,344 10,090 Cost of service revenue1,672 1,890 3,444 3,851 Research and development3,230 3,744 6,854 7,586 Sales and marketing3,114 3,627 5,865 6,908 General and administrative6,079 5,818 11,769 11,445 Total costs and operating expenses19,410 19,996 38,276 39,880 Loss from operations(12,148)(13,378)(23,809)(27,651)Other income (expense):Interest income, net351 838 817 1,821 Other expense, net(50)(23)(111)(52)Total other income, net301 815 706 1,769 Loss before income taxes(11,847)(12,563)(23,103)(25,882)Income tax expense11 15 18 18 Net loss$(11,858)$(12,578)(23,121)(25,900)Net loss per share — basic and diluted$(0.27)$(0.29)$(0.52)$(0.60)Weighted average common shares outstanding — basic and diluted44,648,60243,616,50144,321,56643,431,170

The accompanying notes are an integral part of these condensed consolidated financial statements.

7